Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

172

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01AX03	TEGOZOL	G	Temozolomide - 20mg	100mg	Capsule	967,567 L.L
L01AX03	TEMODAL	B	Temozolomide - 250mg	250mg	Capsule	18,516,505 L.L
L01AX03	TEGOZOL	G	Temozolomide - 250mg	250mg	Capsule	13,397,927 L.L
L01AX03	TEMOZOLOMIDE ACCORD	G	Temozolomide - 250mg	250mg	Capsule, hard	13,397,927 L.L
L01AX03	TEMOZOLOMIDE GP PHARM	G	Temozolomide - 250mg	250mg	Capsule, hard	12,058,004 L.L
L01AX03	TEMOZOLOMIDE ACCORD	G	Temozolomide - 5mg	5mg	Capsule, hard	1,153,017 L.L
L01AX03	TEMOZOLOMIDE GP PHARM	G	Temozolomide - 5mg	5mg	Capsule, hard	1,153,017 L.L
B01AD11	METALYSE	BioTech	Tenecteplase - 10,000IU	10,000IU	Injectable powder for solution+diluent	77,815,572 L.L
J05AF13	VEMLIDY	B	Tenofovir alafenamide fumarate - 25mg	25mg	Tablet, film coated	26,997,299 L.L
J05AF07	VIREAD	B	Tenofovir disoproxil - 245mg	245mg	Tablet, film coated	15,716,313 L.L
J05AF07	TENOFOVIR DISOPROXIL ARROW	G	Tenofovir disoproxil - 245mg	245mg	Tablet, film coated	9,747,613 L.L
J05AF07	TENOFOVIR DISOPROXIL BIOGARAN	G	Tenofovir disoproxil - 245mg	245mg	Tablet, film coated	9,747,613 L.L
J05AF07	TENOREAD	G	Tenofovir disoproxil fumarate - 300mg	300mg	Tablet, film coated	7,129,777 L.L
J05AF07	TENVOR	G	Tenofovir disoproxil fumarate - 300mg	300mg	Tablet, film coated	3,753,352 L.L
M01AC02	REUTENOX	G	Tenoxicam - 20mg	20mg	Tablet, coated	576,508 L.L
M01AC02	SORAL	G	Tenoxicam - 20mg/2ml	20mg/2ml	Injectable lyophilised powder for solution+solvent	588,603 L.L
D01AE15	LAMIFEN	G	Terbinafine HCl - 1%	1%	Cream	350,743 L.L
D01AE15	TERAFAN	G	Terbinafine HCl - 1%	1%	Cream	499,142 L.L
D01AE15	TERMINUS	G	Terbinafine HCl - 1%	1%	Cream	747,176 L.L
D01AE15	TERAFAN	G	Terbinafine HCl - 1%	1%	Solution	355,798 L.L
D01AE15	LAMISIL	B	Terbinafine HCl - 10mg/g	1%	Cream	616,824 L.L
D01AE15	LAMINOX	G	Terbinafine HCl - 10mg/g	10mg/g	Cream	453,067 L.L
D01AE15	LAMISIL	B	Terbinafine HCl - 10mg/ml	1%	Solution	506,629 L.L
D01BA02	APO-TERBINAFINE	G	Terbinafine HCl - 250mg	250mg	Tablet	1,409,691 L.L
D01BA02	BODERM	G	Terbinafine HCl - 250mg	250mg	Tablet	749,992 L.L
D01BA02	LAMIFEN	G	Terbinafine HCl - 250mg	250mg	Tablet	245,923 L.L
D01BA02	LAMINOX	G	Terbinafine HCl - 250mg	250mg	Tablet	725,675 L.L
D01BA02	TERAFAN	G	Terbinafine HCl - 250mg	250mg	Tablet, scored	725,675 L.L
D01BA02	TERMINUS	G	Terbinafine HCl - 250mg	250mg	Tablet	483,783 L.L
L04AA31	AUBAGIO	B	Teriflunomide - 14mg	14mg	Tablet, film coated	38,773,533 L.L

...

172

...